{"id":"parecoxib-valdecoxib-etoricoxib","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Edema"},{"rate":null,"effect":"Dyspepsia"},{"rate":null,"effect":"Cardiovascular events (myocardial infarction, stroke)"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"COX-2 selective inhibitors block the enzyme responsible for producing prostaglandins that drive inflammation, fever, and pain signaling. By sparing COX-1, they aim to reduce gastrointestinal toxicity compared to non-selective NSAIDs, though cardiovascular risks remain a concern with this class.","oneSentence":"These drugs selectively inhibit cyclooxygenase-2 (COX-2) to reduce inflammation and pain without significantly affecting COX-1-mediated gastric protection.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:35:41.670Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute postoperative pain"},{"name":"Rheumatoid arthritis"},{"name":"Osteoarthritis"},{"name":"Ankylosing spondylitis"}]},"trialDetails":[{"nctId":"NCT01361789","phase":"PHASE4","title":"COX-2 Inhibitor Versus Glucocorticoid Versus Both Combined","status":"COMPLETED","sponsor":"Asker & Baerum Hospital","startDate":"2004-01","conditions":"Rupture of Anterior Cruciate Ligament","enrollment":93}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":29,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"parecoxib, valdecoxib, etoricoxib","genericName":"parecoxib, valdecoxib, etoricoxib","companyName":"Asker & Baerum Hospital","companyId":"asker-baerum-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"These drugs selectively inhibit cyclooxygenase-2 (COX-2) to reduce inflammation and pain without significantly affecting COX-1-mediated gastric protection. Used for Acute postoperative pain, Rheumatoid arthritis, Osteoarthritis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}